New IDWeek 2024 study reveals disparities in PrEP uptake across key U.S. populations. While overall PrEP usage has increased, ...
PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.
With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
Learn about the changing trend in pre exposure prophylaxis medication prescription for HIV patients in the US over the past ...
As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...
(HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association. Laura M. Mann ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
PrEP, or pre-exposure prophylaxis, was first approved by the FDA in 2012 to prevent people exposed to HIV from becoming ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...